| In Vivo Cancer Gene Therapy by Adenovirus-mediated Transfer of a Bifunctional Yeast Cytosine Deaminase/Uracil Phosphoribosyltransferase Fusion Gene P Erbs, E Regulier, J Kintz, P Leroy, Y Poitevin, F Exinger, R Jund, ... Cancer research 60 (14), 3813-3822, 2000 | 290 | 2000 |
| Trial watch: oncolytic viruses for cancer therapy J Pol, N Bloy, F Obrist, A Eggermont, J Galon, I Cremer, P Erbs, ... Oncoimmunology 3 (6), e28694, 2014 | 152 | 2014 |
| Trial Watch—Oncolytic viruses and cancer therapy J Pol, A Buqué, F Aranda, N Bloy, I Cremer, A Eggermont, P Erbs, ... Oncoimmunology 5 (2), e1117740, 2016 | 142 | 2016 |
| Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen‐independent growth in prostate cancer J Ceraline, MD Cruchant, E Erdmann, P Erbs, JE Kurtz, B Duclos, ... International journal of cancer 108 (1), 152-157, 2004 | 121 | 2004 |
| Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus J Foloppe, J Kintz, N Futin, A Findeli, P Cordier, Y Schlesinger, ... Gene therapy 15 (20), 1361-1371, 2008 | 117 | 2008 |
| Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death-1 (PD-1) allows their intratumoral delivery and an improved tumor … P Kleinpeter, L Fend, C Thioudellet, M Geist, N Sfrontato, V Koerper, ... Oncoimmunology 5 (10), e1220467, 2016 | 105 | 2016 |
| Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans P Erbs, F Exinger, R Jund Current genetics 31, 1-6, 1997 | 84 | 1997 |
| The enhanced tumor specificity of TG6002, an armed oncolytic vaccinia virus deleted in two genes involved in nucleotide metabolism J Foloppe, J Kempf, N Futin, J Kintz, P Cordier, C Pichon, A Findeli, ... Molecular Therapy-Oncolytics 14, 1-14, 2019 | 76 | 2019 |
| The URH1 uridine ribohydrolase of Saccharomyces cerevisiae JE Kurtz, F Exinger, P Erbs, R Jund Current Genetics 41, 132-141, 2002 | 74 | 2002 |
| Polymeric cups for cavitation-mediated delivery of oncolytic vaccinia virus R Myers, C Coviello, P Erbs, J Foloppe, C Rowe, J Kwan, C Crake, S Finn, ... Molecular Therapy 24 (9), 1627-1633, 2016 | 72 | 2016 |
| New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolism JE Kurtz, F Exinger, P Erbs, R Jund Current genetics 36, 130-136, 1999 | 69 | 1999 |
| Modified vaccinia virus Ankara as a vector for suicide gene therapy P Erbs, A Findeli, J Kintz, P Cordier, C Hoffmann, M Geist, JM Balloul Cancer gene therapy 15 (1), 18-28, 2008 | 64 | 2008 |
| Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1 JD Dias, I Liikanen, K Guse, J Foloppe, M Sloniecka, I Diaconu, ... Clinical Cancer Research 16 (9), 2540-2549, 2010 | 62 | 2010 |
| Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus JK Kaufmann, S Bossow, C Grossardt, S Sawall, J Kupsch, P Erbs, ... Journal of Investigative Dermatology 133 (4), 1034-1042, 2013 | 53 | 2013 |
| Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction … B Heinrich, J Klein, M Delic, K Goepfert, V Engel, L Geberzahn, M Lusky, ... OncoTargets and therapy, 2389-2401, 2017 | 52 | 2017 |
| Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment L Fend, C Remy-Ziller, J Foloppe, J Kempf, S Cochin, L Barraud, N Accart, ... Oncoimmunology 5 (2), e1080414, 2016 | 39 | 2016 |
| Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies K Rittner, V Schreiber, P Erbs, M Lusky Cancer gene therapy 14 (5), 509-518, 2007 | 35 | 2007 |
| Vectorized gene therapy of liver tumors: Proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine F Husseini, JP Delord, C Fournel-Federico, J Guitton, P Erbs, M Homerin, ... Annals of Oncology 28 (1), 169-174, 2017 | 32 | 2017 |
| A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer J Céraline, E Erdmann, P Erbs, M Deslandres-Cruchant, D Jacqmin, ... European journal of endocrinology 148 (1), 99-110, 2003 | 32 | 2003 |
| Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy C Quirin, S Rohmer, I Fernández-Ulibarri, M Behr, A Hesse, S Engelhardt, ... Human gene therapy 22 (4), 389-404, 2011 | 31 | 2011 |
